These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 5015883)
1. Effectiveness and tolerance of cephalexin in children. Helwig H; Kunz H; Hueppchen C Z Kinderheilkd; 1972; 111(4):307-14. PubMed ID: 5015883 [No Abstract] [Full Text] [Related]
2. Cephalexin: effective oral antibiotic for coccal infections. Walker SH; Gonzales EP Md State Med J; 1971 Jan; 20(1):63-5. PubMed ID: 5141500 [No Abstract] [Full Text] [Related]
3. [Treatment with cephalexin monohydrate of urinary tract infections in children. Preliminary report]. De La Torre JA; Filloy L; Mendez Tena E; Olarte J; Torregrosa L Prensa Med Mex; 1970; ():87-91. PubMed ID: 4931124 [No Abstract] [Full Text] [Related]
4. [Bioavailability of new galenic preparations of cephalexin (author's transl)]. Guggenbichler JP; Kienel G Padiatr Padol; 1978; 13(3):315-20. PubMed ID: 673437 [TBL] [Abstract][Full Text] [Related]
6. Absorption and excretion of cephalexin by the newborn infant. Boothman R; Kerr MM; Marshall MJ; Burland WL Arch Dis Child; 1973 Feb; 48(2):147-50. PubMed ID: 4690512 [No Abstract] [Full Text] [Related]
7. [Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions]. Kobayashi Y; Akaishi K; Nishio T; Goto K; Aihara M Jpn J Antibiot; 1972 Apr; 25(2):104-19. PubMed ID: 4561052 [No Abstract] [Full Text] [Related]
8. [Report on the effective dose of a new cephalosporin in peroral administration: cephalexin]. Russo R; Scianaro D; Pagliarulo V Clin Ter; 1972 Jun; 61(5):419-40. PubMed ID: 5051326 [No Abstract] [Full Text] [Related]
9. An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children. Lipman RP; Silverman W Clin Pediatr (Phila); 1977 Sep; 16(9):835-7. PubMed ID: 330074 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Regamey C; Libke RD; Clarke JT; Kirby WM Infection; 1974; 2(3):132-6. PubMed ID: 4415038 [No Abstract] [Full Text] [Related]
11. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties. Speight TM; Brogden RN; Avery GS Drugs; 1972; 3(1):9-78. PubMed ID: 4559812 [No Abstract] [Full Text] [Related]
12. [Pharmacokinetics of cephalexin in adults and children]. Simon C; Sievers G; Rohwedder HJ; Malerczyk V Dtsch Med Wochenschr; 1970 Oct; 95(42):2103-8. PubMed ID: 5475487 [No Abstract] [Full Text] [Related]
13. Bioavailability of oral antibiotics in cystic fibrosis. Guggenbichler JP; Kienel G Monogr Paediatr; 1979; 10():34-40. PubMed ID: 572479 [No Abstract] [Full Text] [Related]
14. Oral ceftibuten switch therapy for acute pyelonephritis in children. Vilaichone A; Watana D; Chaiwatanarat T J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S61-7. PubMed ID: 11529382 [TBL] [Abstract][Full Text] [Related]
15. Cephalexin in the treatment of gonorrhea. Taylor WA; Holloway WJ Int J Clin Pharmacol; 1972 Apr; 6(1):7-9. PubMed ID: 5048674 [No Abstract] [Full Text] [Related]
16. [Vibramycin in treatment of pyelonephritis in children]. Gerkowicz T; Bekajlowa B Pol Tyg Lek; 1971 May; 26(22):832-4. PubMed ID: 5091033 [No Abstract] [Full Text] [Related]
17. Clinical evaluation of cephalexin in the treatment of urinary tract infections. Eyckmans L Chemotherapy; 1970; 15(5):322-30. PubMed ID: 5495425 [No Abstract] [Full Text] [Related]